TESARO, Inc. News Headlines

TSRO 
$34.75
*  
0.84
2.48%
Get TSRO Alerts
*Delayed - data as of Nov. 26, 2014  -  Find a broker to begin trading TSRO now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    TSRO After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Myriad Genetics, Tesaro Tie Up for myChoice Cancer Test - Analyst Blog
11/21/2014 3:10:00 PM - Zacks.com


TESARO, Myriad Announce Companion Diagnostics Collaboration - Quick Facts
11/20/2014 8:23:00 AM - RTT News


Tesaro Q3 Loss Widens - Quick Facts
11/5/2014 8:58:00 PM - RTT News


Weakness Seen in Tesaro, Inc. (TSRO): Stock Tumbles 9.0% - Tale of the Tape
9/24/2014 7:54:00 AM - Zacks.com


Cramer's Mad Money - The World Is Slowing, And Slowing Fast (9/16/14)
9/17/2014 5:29:00 AM - Seeking Alpha


TESARO Seeks FDA Approval for NK-1 Receptor Rolapitant - Analyst Blog
9/9/2014 4:00:00 PM - Zacks.com


EBS Gets Funded, HPTX Pulls Plug On Diabetes Drug Candidate, Panther On The Mend
9/8/2014 11:10:00 PM - RTT News


Sector Update: Health Care Stocks End Mixed; Opko Health, Tesaro Climb After Submitting New Drug Application for Anti-Nausea Medication
9/8/2014 3:13:18 PM - MT Newswires


Sector Update: Health Care
9/8/2014 3:08:04 PM - MT Newswires


OPKO Licensee TESARO Submits NDA For Rolapitant
9/8/2014 12:49:00 PM - RTT News


TESARO Reports NDA Submission Of Rolapitant To U.S. FDA - Quick Facts
9/8/2014 8:09:00 AM - RTT News


TESARO Will Present At The Baird's Health Care Conference;Webcast At 1:25 PM ET
9/4/2014 12:25:00 PM - RTT News


TESARO (TSRO) Slips on Wider-than-Expected Q2 Loss - Analyst Blog
7/30/2014 2:10:00 PM - Zacks.com


Myriad Genetics Poised on Strong Fundamentals - Analyst Blog
7/10/2014 5:10:00 PM - Zacks.com


Commit To Purchase Tesaro At $25, Earn 14.2% Annualized Using Options
7/3/2014 11:05:22 AM - BNK Invest


Tesaro (TSRO) in Focus: Stock Moves 8.9% Higher - Tale of the Tape
7/2/2014 8:46:00 AM - Zacks.com


TSRO Makes Bullish Cross Above Critical Moving Average
7/1/2014 12:10:03 PM - BNK Invest


OPKO CEO Is Building A Pharma Powerhouse And Continuously Buying Shares
6/20/2014 6:04:43 PM - GuruFocus


Tesaro, Inc. (TSRO) Looks Strong as Stock Rallies 21% - Tale of the Tape
5/13/2014 7:44:00 AM - Zacks.com


Myriad Genetics Inks HRD Alliance with Tesaro - Analyst Blog
3/27/2014 2:00:01 PM - Zacks.com


Ignyta: Now Public With A Targeted Oncology Pipeline Poised For Success
2/24/2014 8:49:00 AM - Seeking Alpha


SA PRO: Top Long And Short Ideas, Tuesday February 18
2/19/2014 7:30:00 AM - Seeking Alpha


SA PRO: Top Long And Short Ideas, Tuesday January 21
1/22/2014 7:30:00 AM - Seeking Alpha


Moving Average Crossover: Great News for TESARO (TSRO)? - Tale of the Tape
1/16/2014 6:39:01 AM - Zacks.com


Tesaro (TSRO) Jumps: Stock Moves 8.1% Higher - Tale of the Tape
1/13/2014 9:46:01 AM - Zacks.com